|
LONDON (AP) - Pharmaceutical companies and Alzheimer's patient advocates went to Britain's High Court on Monday in a bid to force the state-run health service to give all patients access to three drugs to treat the brain-destroying disease.
The case is the latest in a series of legal challenges to Britain's National Health Service, which offers free health care and low-cost medicines to all Britons — but is regularly accused of rationing access to treatment.
Drug companies Eisai Co. Ltd. and Pfizer Inc., along with the Alzheimer's Society, want to overturn a decision by the government's medicines watchdog not to approve a group of drugs known as acetyl cholinesterase inhibitors for patients in early stages of the disease.
|